| 000 | 02670 a2200745 4500 | ||
|---|---|---|---|
| 005 | 20250517122249.0 | ||
| 264 | 0 | _c20180223 | |
| 008 | 201802s 0 0 eng d | ||
| 022 | _a1534-4681 | ||
| 024 | 7 |
_a10.1245/s10434-016-5600-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWhitworth, Pat | |
| 245 | 0 | 0 |
_aChemosensitivity and Endocrine Sensitivity in Clinical Luminal Breast Cancer Patients in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST) Predicted by Molecular Subtyping. _h[electronic resource] |
| 260 |
_bAnnals of surgical oncology _cMar 2017 |
||
| 300 |
_a669-675 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase IV; Comparative Study; Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aAnastrozole |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aAromatase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aBreast Neoplasms _xclassification |
| 650 | 0 | 4 |
_aBridged-Ring Compounds _xadministration & dosage |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 | _aClinical Decision-Making |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 | _aDocetaxel |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Expression Profiling |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 | _aIn Situ Hybridization, Fluorescence |
| 650 | 0 | 4 | _aLetrozole |
| 650 | 0 | 4 | _aMastectomy, Segmental |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMolecular Typing _xmethods |
| 650 | 0 | 4 | _aNeoadjuvant Therapy |
| 650 | 0 | 4 |
_aNitriles _xadministration & dosage |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aReceptor, ErbB-2 _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, Estrogen _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, Progesterone _xmetabolism |
| 650 | 0 | 4 | _aRegistries |
| 650 | 0 | 4 |
_aTamoxifen _xadministration & dosage |
| 650 | 0 | 4 |
_aTaxoids _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTriazoles _xadministration & dosage |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aBeitsch, Peter | |
| 700 | 1 | _aMislowsky, Angela | |
| 700 | 1 | _aPellicane, James V | |
| 700 | 1 | _aNash, Charles | |
| 700 | 1 | _aMurray, Mary | |
| 700 | 1 | _aLee, Laura A | |
| 700 | 1 | _aDul, Carrie L | |
| 700 | 1 | _aRotkis, Michael | |
| 700 | 1 | _aBaron, Paul | |
| 700 | 1 | _aStork-Sloots, Lisette | |
| 700 | 1 | _ade Snoo, Femke A | |
| 700 | 1 | _aBeatty, Jennifer | |
| 773 | 0 |
_tAnnals of surgical oncology _gvol. 24 _gno. 3 _gp. 669-675 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1245/s10434-016-5600-x _zAvailable from publisher's website |
| 999 |
_c26540648 _d26540648 |
||